# Cluster5-5 Analysis

## Proteins: 

ARID4B, ARID5B, JARID2, KDM5A, MIER2, SHPRH, SUDS3, TFDP1, TNRC18

### Nucleoplasmic Chromatin Remodeling and Transcriptional Regulation System

**Summary**

The human protein system analyzed in this report consists of ARID4B, JARID2, TFDP1, MIER2, ARID5B, SUDS3, KDM5A, SHPRH, and TNRC18. These proteins are predominantly localized in the nucleoplasm and are involved in various aspects of chromatin remodeling, transcriptional regulation, and DNA binding. The system is involved in negative regulation of transcription by RNA polymerase II, chromatin remodeling, and histone demethylase activity. Based on the functions and cellular locations of these proteins, we propose the name "Nucleoplasmic Chromatin Remodeling and Transcriptional Regulation System" for this protein system.

The proteins in this system are involved in several biological processes, including negative regulation of cell migration, negative regulation of transforming growth factor beta receptor signaling pathway, and stem cell population maintenance. Some proteins, such as ARID4B and SUDS3, are part of the Sin3 complex, which plays a role in transcriptional regulation. Other proteins, like JARID2 and KDM5A, exhibit histone demethylase activity and are involved in facultative heterochromatin formation. MIER2 and SUDS3 are associated with histone deacetylase activity and binding, contributing to histone deacetylation and transcriptional regulation.

**References**

1. Klose, R. J., Kallin, E. M., & Zhang, Y. (2006). JmjC-domain-containing proteins and histone demethylation. *Nature Reviews Genetics*, 7(9), 715-727. [DOI: 10.1038/nrg1945](https://doi.org/10.1038/nrg1945)

2. Lai, A. Y., & Wade, P. A. (2011). Cancer biology and NuRD: a multifaceted chromatin remodelling complex. *Nature Reviews Cancer*, 11(8), 588-596. [DOI: 10.1038/nrc3091](https://doi.org/10.1038/nrc3091)

3. Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B. E., & Reinberg, D. (2010). Jarid2 and PRC2, partners in regulating gene expression. *Genes & Development*, 24(4), 368-380. [DOI: 10.1101/gad.1886410](https://doi.org/10.1101/gad.1886410)

4. Nagy, Z., & Tora, L. (2007). Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. *Oncogene*, 26(37), 5341-5357. [DOI: 10.1038/sj.onc.1210604](https://doi.org/10.1038/sj.onc.1210604)

5. Silverstein, R. A., & Ekwall, K. (2005). Sin3: a flexible regulator of global gene expression and genome stability. *Current Genetics*, 47(1), 1-17. [DOI: 10.1007/s00294-004-0535-3](https://doi.org/10.1007/s00294-004-0535-3)

### Validated References: 

None





## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| nucleoplasm | 9 | ARID4B, JARID2, TFDP1, MIER2, ARID5B, SUDS3, KDM5A, SHPRH, TNRC18 |
| protein binding | 8 | ARID4B, TFDP1, MIER2, ARID5B, SUDS3, KDM5A, SHPRH, TNRC18 |
| nucleus | 7 | ARID4B, JARID2, TFDP1, MIER2, ARID5B, SUDS3, KDM5A |
| negative regulation of transcription by RNA polymerase II | 6 | ARID4B, JARID2, MIER2, ARID5B, SUDS3, KDM5A |
| cytosol | 4 | ARID4B, TFDP1, SUDS3, TNRC18 |
| DNA binding | 4 | JARID2, ARID5B, KDM5A, SHPRH |
| chromatin remodeling | 4 | JARID2, MIER2, SUDS3, KDM5A |
| transcription cis-regulatory region binding | 3 | ARID4B, ARID5B, KDM5A |
|  transcription by RNA polymerase II | 3 | ARID4B, TFDP1, ARID5B |
| mitochondrion | 3 | ARID4B, JARID2, TNRC18 |
|  DNA-binding transcription factor activity | 3 | TFDP1, ARID5B, KDM5A |
| transcription by RNA polymerase II | 2 | ARID4B, TFDP1 |
| negative regulation of cell migration | 2 | ARID4B, SUDS3 |
| negative regulation of transforming growth factor beta receptor signaling pathway | 2 | ARID4B, SUDS3 |
| negative regulation of stem cell population maintenance | 2 | ARID4B, SUDS3 |
|  stem cell population maintenance | 2 | ARID4B, SUDS3 |
| Sin3 complex | 2 | ARID4B, SUDS3 |
| chromatin binding | 2 | JARID2, TNRC18 |
| histone demethylase activity | 2 | JARID2, KDM5A |
| histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 2 | JARID2, KDM5A |
| liver development | 2 | JARID2, ARID5B |
| facultative heterochromatin formation | 2 | JARID2, KDM5A |
| cellular response to leukemia inhibitory factor | 2 | JARID2, ARID5B |
| cytoplasm | 2 | TFDP1, MIER2 |
| histone deacetylase activity | 2 | MIER2, SUDS3 |
| histone deacetylase binding | 2 | MIER2, SUDS3 |
| histone deacetylation | 2 | MIER2, SUDS3 |
| transcription coactivator activity | 2 | ARID5B, KDM5A |
| negative regulation of DNA-templated transcription | 2 | ARID5B, SUDS3 |
|  DNA-templated transcription | 2 | ARID5B, KDM5A |

